GTX

PHARMACEUTICALS, BIOCHEMICALS AND THERAPEUTIC COMPOSITIONS, NAMELY EXPRESSION VECTORS, RECOMBINANT DNA PRODUCTS, NUCLEOTIDE, PRODRUGS, CLONED DNA, AND ORGANIC PROTEIN, FOR USE IN TREATING CANCER BY MEANS OF GENE THERAPY